What is the recommended continuous intravenous infusion dose of midazolam for adults and pediatric patients?

Midazolam Continuous Infusion Dosing

For continuous IV infusion in adults, start midazolam at 0.02-0.10 mg/kg/hr (approximately 1-7 mg/hr for a 70 kg patient), titrating to effect; in pediatric patients (non-neonatal), initiate with a loading dose of 0.05-0.2 mg/kg over 2-3 minutes followed by continuous infusion at 0.06-0.12 mg/kg/hr (1-2 mcg/kg/min); in neonates, avoid loading doses and start at 0.03 mg/kg/hr (<32 weeks) or 0.06 mg/kg/hr (≥32 weeks). 1

Adult Dosing

ICU Sedation

• Initial infusion rate: 0.02-0.10 mg/kg/hr, with most patients adequately sedated at the lower end of this range 2
• Target plasma concentration: 150-220 ng/mL typically provides adequate sedation 2
• Titration: Adjust by 25% increments based on sedation goals 1
• Loading dose: May use 0.05-0.15 mg/kg IV over 2-3 minutes if rapid sedation needed, though this increases hypotension risk in hemodynamically unstable patients 1

Refractory Status Epilepticus

• High-dose protocol: Start at 0.2 mg/kg/hr and titrate up to 0.4-2.0 mg/kg/hr as needed 3
• Loading dose: 0.2 mg/kg IV bolus 3
• Evidence shows high-dose midazolam (median 0.4 mg/kg/hr) reduces withdrawal seizures (15% vs 64%) and may lower mortality compared to traditional low-dose protocols (0.2 mg/kg/hr) 3

Pediatric Dosing (Non-Neonatal)

ICU Sedation with Intubation

• Loading dose: 0.05-0.2 mg/kg IV over 2-3 minutes 1
• Continuous infusion: 0.06-0.12 mg/kg/hr (1-2 mcg/kg/min) 1
• Titration: Increase or decrease by 25% increments, or give supplemental boluses 1
• Historical data shows effective sedation at 0.4-4 mcg/kg/min (0.024-0.24 mg/kg/hr) 4

Status Epilepticus

• Loading dose: 0.15 mg/kg IV bolus 5
• Initial infusion: 0.1-0.15 mg/kg/hr 5
• Titration: Increase gradually up to 0.3 mg/kg/hr until seizure control 5
• Low-dose early approach: Recent evidence shows <0.2 mg/kg/hr administered early (after single benzodiazepine or ASM) achieves 59% response vs 37% when used after multiple ASMs 6
• For refractory SE: Loading dose 0.15-0.2 mg/kg, then 1 mcg/kg/min, increasing by 1 mcg/kg/min increments every 15 minutes (maximum 5 mcg/kg/min) 7

Neonatal Dosing

• NO loading dose - run infusion more rapidly for first several hours instead 1
• <32 weeks gestation: 0.03 mg/kg/hr (0.5 mcg/kg/min) 1
• ≥32 weeks gestation: 0.06 mg/kg/hr (1 mcg/kg/min) 1
• Critical consideration: Neonates have markedly prolonged elimination half-life (6.5-12 hours) and reduced clearance (0.07-0.12 L/hr/kg) compared to older children 1
• Reassess infusion rate frequently, especially after first 24 hours, to minimize drug accumulation 1

Critical Safety Considerations

Respiratory Depression Risk

• Highest risk: Combination with opioids creates synergistic respiratory depression 8, 9, 8
• Timing: Apnea may occur up to 30 minutes after last dose 9
• Monitoring: Continuous pulse oximetry and respiratory monitoring mandatory 1
• Have flumazenil immediately available, though it reverses anticonvulsant effects 7

Hemodynamic Instability

• Hypotension: More common with rapid administration and higher doses 3
• High-risk patients: Critically ill, hemodynamically compromised, or receiving inotropic support 1
• Mitigation: Titrate loading doses in small increments in unstable patients 1

Special Populations Requiring Dose Reduction

• Elderly (>60 years): Reduce by ≥20%; half-life doubles, volume of distribution increases 15-100% 9, 1
• Hepatic impairment: Clearance reduced 50%, half-life increases 2.5-fold 1
• Obesity: Half-life increases from 2.3 to 5.9 hours due to increased volume of distribution 1
• Renal failure: Prolonged elimination (7.6 vs 13 hours), though parent drug clearance may be preserved 1

Drug Accumulation

• Prolonged infusions: Midazolam accumulates in peripheral tissues with continuous infusion 1
• Active metabolite: 1-hydroxy-midazolam accumulates significantly in renal failure (10-fold higher than parent drug) with half-life >25 hours 1
• Mitigation: Use lowest effective infusion rate; reassess frequently 1

Procedural Sedation (Bolus Dosing for Context)

While the question asks about infusion, understanding bolus dosing provides context for loading doses:

Adults <60 years

• Initial: 1-2 mg IV over 1-2 minutes (max 0.03 mg/kg) 8, 9, 8
• Additional: 1 mg increments every 2 minutes 8, 9, 8
• Total rarely exceeds 6 mg 8, 9, 8

Pediatrics (Procedural)

• 6 months-5 years: 0.05-0.1 mg/kg (max 0.6 mg/kg, usually ≤6 mg total) 8
• 6-12 years: 0.025-0.05 mg/kg (max 0.4 mg/kg, usually ≤10 mg total) 8
• 12-16 years: Dose as adults 8

Common Pitfalls

1. Inadequate time for peak effect: Wait 3-5 minutes between doses; peak CNS effect occurs at 3-4 minutes IV 8, 9, 8
2. Rapid administration: Associated with more apneic episodes 9
3. Underestimating neonatal sensitivity: Extreme caution in preterm/term infants without intubation due to apnea risk 1
4. Ignoring concomitant medications: H2-receptor antagonists increase bioavailability 30%; P450-3A4 inhibitors (erythromycin) delay elimination 9, 1
5. Delayed recognition of status epilepticus refractoriness: Early low-dose midazolam infusion more effective than delayed high-dose 6